Clinical trial software company Florence Healthcare announced Wednesday it had scored $27 million in a Series C-1 round led by Insight Partners.
The startup said the investment brings its total raise to $114.1 million. Florence announced an $80 million Series C in May 2021 and a $7.1 million Series B in 2019.
WHAT IT DOES
Florence offers tools for managing clinical trials, including remotely...
Asia-Pacific property and retail group Metro Holdings through its subsidiary Metro ARC Investments is buying a 10% interest in DocMed, the digital health arm of Singaporean consumer healthcare group Hyphens Pharma, for SG$6 million ($4.3 million).
The investment will represent a Series A funding for DocMed, later raising its valuation to SG$60 million ($43.5 million) based on the subscription...
23andMe reported a $217 million net loss during its fiscal year 2022, which ended March 31, compared with $184 million during the prior year.
The consumer genetics company also posted a loss of $70 million during its fourth quarter, compared with $67 million during Q4 2021. 23andMe attributed the increase in net loss during the quarter to increased operating expenses driven by sales and...
Singapore-headquartered online pharmacy platform SwipeRx has raised $27 million in a Series B funding round led by MDI Ventures.
It also received backing from global investors, including the Bill & Melinda Gates Foundation, Johnson & Johnson Impact Ventures, and Susquehanna International Group.
WHAT IT DOES
Formerly mClinica Pharmacy Solutions, SwipeRx operates an online platform where...
Tohoku University's Tohoku Medical Megabank Organization, pharmaceutical firms Daiichi Sankyo and Takeda Pharmaceutical Co., and medical IT company MICIN have started a collaborative research project to track long-term lifestyle habits to drive the creation of new drugs.
According to a press statement, the organisations will loan wearable tracking devices to about 2,000 participants. Over a year...
ICT provider Fujitsu has partnered with research institute Riken in Japan to jointly work on new-generation IT drug discovery technology to accelerate digital transformation in drug discovery.
According to a press statement, the organisations will utilise the supercomputer Fugaku, which they have developed together in the past decade, along with simulation AI technologies. Through these...
Digital cancer care company Kaiku Health has entered into a strategic partnership with pharma and diagnostics giant Roche to offer Kaiku's tools for symptom management and support to clinics and patients.
Finnish-born Kaiku provides a digital platform where patients can input their symptoms as they undergo cancer treatment, receive feedback for lower-acuity concerns and keep the care team...
Prescription digital therapeutics startup MedRhythms has entered into a licensing agreement with Biogen to develop and commercialize its MR-004 product, which aims to improve mobility for people with multiple sclerosis (MS).
Under the deal, MedRhythms would receive a $3 million upfront payment from Biogen, with the potential to earn up to $117.5 million if certain development and commercial...
Decentralized clinical trial company Curebase raised $40 million in a Series B round led by Industry Ventures.
Acrew Capital, World Innovation Lab, Positive Sum, Gaingels, GGV Capital, Bold Capital and Xfund participated in the funding, which also included a strategic investment from pharma giant Gilead Sciences. The round brings Curebase's total raise to $59 million.
WHAT IT DOES
Curebase offers...
_18.jpg?itok=q487l_qs "Businesspeople shaking hands")
